The role of vasoactive mediators in portal hypertension.
García-Pagán
J C
JC
Department of Medicine, University of Barcelona, Spain.
Bosch
J
J
Rodés
J
J
D003097:Collateral Circulation / Q000502:physiology; D004231:Diuresis / Q000502:physiology; D016232:Endothelins / Q000502:physiology; D011464:Epoprostenol / Q000502:physiology; D005934:Glucagon / Q000502:physiology; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology / Q000503:physiopathology*; D009569:Nitric Oxide / Q000502:physiology; D017082:Portal Pressure / Q000502:physiology; D012079:Renal Circulation / Q000502:physiology; D014655:Vascular Resistance
D016232:Endothelins; D009569:Nitric Oxide; D005934:Glucagon; D011464:Epoprostenol